465 filings
Page 4 of 24
4
cxotxrl k91w
19 Apr 21
Sio Gene Therapies / David W. Nassif ownership change
4:53pm
4
hdlbuy a8wft
19 Apr 21
Sio Gene Therapies / Gavin Corcoran ownership change
4:52pm
4
an5kw
19 Apr 21
Sio Gene Therapies / Pavan Cheruvu ownership change
4:51pm
8-K
3vv6 5gp9e
5 Apr 21
Departure of Directors or Certain Officers
5:10pm
4
dsk69jedx 26hnce3e
24 Mar 21
Sio Gene Therapies / Pavan Cheruvu ownership change
7:21pm
4
t79ci50 ggiyylrh0
22 Mar 21
Sio Gene Therapies / David W. Nassif ownership change
9:25pm
4
gohtk12nyw2lvb
19 Mar 21
Sio Gene Therapies / Gavin Corcoran ownership change
4:58pm
4
peud8n7w
19 Mar 21
Sio Gene Therapies / Pavan Cheruvu ownership change
4:55pm
8-K
w171i0rxub0oium
15 Mar 21
Sio Gene Therapies Provides Update on Cash Position and Major Upcoming GM1 Gangliosidosis Program Milestones
7:02am
SC 13G
xvg5kfvr2gituc9jhk8
26 Feb 21
Sio Gene Therapies / SUVRETTA CAPITAL MANAGEMENT ownership change
4:24pm
SC 13G
2czkb33c c01jsn
16 Feb 21
Sio Gene Therapies / Consonance Capital Management ownership change
2:40pm
SC 13G/A
6oafm
16 Feb 21
Sio Gene Therapies / SPHERA FUNDS MANAGEMENT ownership change
9:00am
SC 13G
ipqcgf2gnnu
16 Feb 21
Sio Gene Therapies / Consonance Capital Management ownership change
12:00am
8-K
d107e3ejm9ne
9 Feb 21
Results of Operations and Financial Condition
7:02am
8-K
8odehb1oat
4 Feb 21
Sio Gene Therapies Announces Receipt of $11.6 Million from Closing of the Sale of Arvelle Therapeutics
7:02am
8-K
b5bjohio1 y1vjh9khb
3 Feb 21
Regulation FD Disclosure
7:03am
8-K
kw1m2a14hl0uog
4 Jan 21
Sio Gene Therapies to sell Arvelle Stake as part of Angelini Pharma’s Acquisition of Arvelle Therapeutics
8:01am
8-K
wd1bgfivxoznmoto7 ua
18 Dec 20
Entry into a Material Definitive Agreement
6:00am
424B5
8zcoo0
16 Dec 20
Prospectus supplement for primary offering
6:59am